Learn About T-Cell Lymphoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
City Of Hope Medical Foundation
Christiane Querfeld is a Dermatologist in Newport Beach, California. Dr. Querfeld and is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. Her top areas of expertise are Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome.
Stanford Health Care
Youn-hee Kim is a Dermatologist in Stanford, California. Dr. Kim has been practicing medicine for over 41 years and is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Mycosis Fungoides, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Sezary Syndrome.
City Of Hope Medical Foundation
Steven Rosen is a Hematologist Oncology specialist and a Hematologist in South Pasadena, California. Dr. Rosen and is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Non-Hodgkin Lymphoma, Chronic B-Cell Leukemia (CBCL), and Bone Marrow Transplant.
Summary: This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on people with relapsed or refractory NK-cell or T-cell lymphoma. This study has three parts: dose escalation (Part 1), dose expansion (Part 2), and TFH/T-PLL cohort expansion (Part 3).
Background: Lymphoma is a type of blood cancer. Blood cell transplant can cure some people with lymphoma. Researchers want to see if they can limit the complications transplant can cause.